NIDA Home > About NIDA > Organization   

National Advisory Council on Drug Abuse



Department of Health and Human Services
National Institutes of Health
National Institute on Drug Abuse

104th Meeting
National Advisory Council on Drug Abuse
Neuroscience Center - Conference Room C
6001 Executive Boulevard, Bethesda, MD.


February 2, 2010

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

2:00 p.m. Call to Order
Nora D. Volkow, M.D., Director, NIDA

Review of and Policy Procedures
Teresa Levitin, Ph.D., Executive Secretary,
National Advisory Council on Drug Abuse

Council Review of Grant Applications
Nora Volkow, M.D., Director, and
Timothy P. Condon, Ph.D., Deputy Director, NIDA

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Phil Skolnick, D.Sc., Ph.D., Director

Division of Basic Neuroscience and Behavioral Research (DBNBR)
David Shurtleff, Ph.D., Director

Division of Clinical Neuroscience and Behavioral Research (DCNBR)
Joseph Frascella, Ph.D., Director

Division of Epidemiology, Services and Prevention Research (DESPR)
Wilson Compton, M.D., M.P.E., Director
Office of Science Policy and Communications (OSPC)
Lucinda Miner, Ph.D., Deputy Directo

American Recovery and Reinvestment Act (ARRA)
Christine Colvis, Ph.D., Director of Program Integration
5:00 p.m. Adjourn

February 3, 2010

Open Session

8:30 - 9:00 a.m. Opening and Welcome
Nora Volkow, M.D., Director, NIDA
9:00 - 10:00 a.m. Director's Report
Nora Volkow, M.D.
Director, NIDA
10:00 - 10:45 a.m. Council Discussion
10:45 - 11:00 a.m. Break
11:00 - 11:15 a.m. Council Procedures/Delegation Of Authority
Teresa Levitin, Ph.D.
Director, Office of Extramural Affairs, NIDA
11:15 - 11:45 a.m. Update from the Center for Clinical Trials Network
Betty Tai, Ph.D.
Director, Center for Clinical Trials Network, NIDA
11:45 - Noon Public Comments
Noon - 1:00 p.m. Lunch
1:00 - 2:00 p.m. Update on Meetings of the Substance Use, Abuse & Addiction (SUAA), Working Group of the SMRB
William Roper, M.D.,
Chairman, SUAA Working Group, Scientific Mgmt Review Board (SMRB), NIH
2:00 p.m. Adjourn

About NIDA Contents